Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis.

Pseudoporphyria is characterized by erythema, blistering, and scarring on sun-exposed skin. Nonsteroidal antiinflammatory drugs (NSAIDs) are implicated in the etiology of this condition. In a 1-year prospective study of children attending the pediatric rheumatology clinic in Edinburgh we found a pre...

Full description

Bibliographic Details
Main Authors: De Silva, B, Banney, L, Uttley, W, Luqmani, R, Schofield, O
Format: Journal article
Language:English
Published: 2000
_version_ 1826303833690603520
author De Silva, B
Banney, L
Uttley, W
Luqmani, R
Schofield, O
author_facet De Silva, B
Banney, L
Uttley, W
Luqmani, R
Schofield, O
author_sort De Silva, B
collection OXFORD
description Pseudoporphyria is characterized by erythema, blistering, and scarring on sun-exposed skin. Nonsteroidal antiinflammatory drugs (NSAIDs) are implicated in the etiology of this condition. In a 1-year prospective study of children attending the pediatric rheumatology clinic in Edinburgh we found a prevalence of pseudoporphyria of 10.9% in children taking NSAIDs for juvenile idiopathic arthritis. Naproxen was the most commonly implicated NSAID, independent of dosage. Blue/gray eye color was an independent risk factor for the development of pseudoporphyria. We would advise caution in prescribing naproxen in these children to prevent disfiguring facial scarring.
first_indexed 2024-03-07T06:08:42Z
format Journal article
id oxford-uuid:eeb73dda-ea46-4edd-bc15-c1c570f86d0c
institution University of Oxford
language English
last_indexed 2024-03-07T06:08:42Z
publishDate 2000
record_format dspace
spelling oxford-uuid:eeb73dda-ea46-4edd-bc15-c1c570f86d0c2022-03-27T11:34:58ZPseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:eeb73dda-ea46-4edd-bc15-c1c570f86d0cEnglishSymplectic Elements at Oxford2000De Silva, BBanney, LUttley, WLuqmani, RSchofield, OPseudoporphyria is characterized by erythema, blistering, and scarring on sun-exposed skin. Nonsteroidal antiinflammatory drugs (NSAIDs) are implicated in the etiology of this condition. In a 1-year prospective study of children attending the pediatric rheumatology clinic in Edinburgh we found a prevalence of pseudoporphyria of 10.9% in children taking NSAIDs for juvenile idiopathic arthritis. Naproxen was the most commonly implicated NSAID, independent of dosage. Blue/gray eye color was an independent risk factor for the development of pseudoporphyria. We would advise caution in prescribing naproxen in these children to prevent disfiguring facial scarring.
spellingShingle De Silva, B
Banney, L
Uttley, W
Luqmani, R
Schofield, O
Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis.
title Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis.
title_full Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis.
title_fullStr Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis.
title_full_unstemmed Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis.
title_short Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis.
title_sort pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis
work_keys_str_mv AT desilvab pseudoporphyriaandnonsteroidalantiinflammatoryagentsinchildrenwithjuvenileidiopathicarthritis
AT banneyl pseudoporphyriaandnonsteroidalantiinflammatoryagentsinchildrenwithjuvenileidiopathicarthritis
AT uttleyw pseudoporphyriaandnonsteroidalantiinflammatoryagentsinchildrenwithjuvenileidiopathicarthritis
AT luqmanir pseudoporphyriaandnonsteroidalantiinflammatoryagentsinchildrenwithjuvenileidiopathicarthritis
AT schofieldo pseudoporphyriaandnonsteroidalantiinflammatoryagentsinchildrenwithjuvenileidiopathicarthritis